Burney CO Abbott Laboratories Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Abbott Laboratories stock. As of the latest transaction made, Burney CO holds 24,907 shares of ABT stock, worth $2.87 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

24,907

Previous 27,738 10.21%

Holding current value

$2.87 Million

Previous $2.88 Million 1.49%

% of portfolio

0.11%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$100.07 - $118.13 $283,298 - $334,426	-2,831 Reduced 10.21%	24,907 $2.84 Million
Q2 2024 Jul 29, 2024	SELL	$100.73 - $112.44 $94,887 - $105,918	-942 Reduced 3.28%	27,738 $2.88 Million
Q1 2024 May 22, 2024	SELL	$109.52 - $120.96 $114,229 - $126,161	-1,043 Reduced 3.51%	28,680 $3.26 Million
Q4 2023 Feb 12, 2024	SELL	$90.19 - $110.4 $190,571 - $233,275	-2,113 Reduced 6.64%	29,723 $3.27 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $43,848 - $52,610	459 Added 1.46%	31,836 $3.08 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $177,876 - $198,191	-1,765 Reduced 5.33%	31,377 $3.42 Million
Q1 2023 May 10, 2023	SELL	$96.86 - $114.01 $232,754 - $273,966	-2,403 Reduced 6.76%	33,142 $3.36 Million
Q4 2022 Feb 06, 2023	SELL	$95.06 - $111.52 $1.35 Million - $1.58 Million	-14,191 Reduced 28.53%	35,545 $3.9 Million
Q3 2022 Nov 15, 2022	SELL	$96.76 - $112.03 $7.89 Million - $9.13 Million	-81,501 Reduced 62.1%	49,736 $4.81 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $255,072 - $308,301	2,499 Added 1.94%	131,237 $14.3 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $1.42 Million - $1.73 Million	12,414 Added 10.67%	128,738 $15.2 Million
Q4 2021 Feb 11, 2022	BUY	$115.53 - $141.46 $9.97 Million - $12.2 Million	86,284 Added 287.23%	116,324 $16.4 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $105,577 - $116,799	-905 Reduced 2.92%	30,040 $3.55 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $25,706 - $30,260	-243 Reduced 0.78%	30,945 $3.59 Million
Q1 2021 May 13, 2021	SELL	$108.84 - $128.23 $131,261 - $154,645	-1,206 Reduced 3.72%	31,188 $3.74 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $117,180 - $127,692	-1,116 Reduced 3.33%	32,394 $3.55 Million
Q3 2020 Dec 14, 2020	SELL	$91.64 - $111.29 $57,824 - $70,223	-631 Reduced 1.85%	33,510 $3.65 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $159,189 - $203,742	-2,079 Reduced 5.74%	34,141 $3.12 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $268,115 - $392,058	-4,268 Reduced 10.54%	36,220 $2.86 Million
Q4 2019 Feb 14, 2020	SELL	$78.51 - $87.4 $76,154 - $84,778	-970 Reduced 2.34%	40,488 $3.52 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $398,560 - $432,163	-4,870 Reduced 10.51%	41,458 $3.47 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $112,308 - $130,985	-1,541 Reduced 3.22%	46,328 $3.9 Million
Q1 2019 May 13, 2019	SELL	$66.22 - $80.06 $281,898 - $340,815	-4,257 Reduced 8.17%	47,869 $3.83 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $283,219 - $320,846	4,320 Added 9.04%	52,126 $3.77 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $362,366 - $437,152	-5,959 Reduced 11.08%	47,806 $3.51 Million
Q2 2018 Aug 13, 2018	BUY	$57.57 - $63.54 $208,748 - $230,396	3,626 Added 7.23%	53,765 $3.28 Million
Q1 2018 May 08, 2018	SELL	$56.27 - $63.62 $246,575 - $278,782	-4,382 Reduced 8.04%	50,139 $3 Million
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $444,953 - $476,368	8,289 Added 17.93%	54,521 $3.11 Million
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $87,228 - $97,356	-1,815 Reduced 3.78%	46,232 $2.48 Million
Q3 2017 Nov 09, 2017	BUY	$48.06 - $53.64 $2.31 Million - $2.58 Million	48,047	48,047 $2.34 Million

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.31B

Call Options Held

8.74M

Put Options Held

7.89M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account